These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 34228538)

  • 1. Enhanced Antibacterial Activity of Repurposed Mitomycin C and Imipenem in Combination with the Lytic Phage vB_KpnM-VAC13 against Clinical Isolates of Klebsiella pneumoniae.
    Pacios O; Fernández-García L; Bleriot I; Blasco L; González-Bardanca M; López M; Fernández-Cuenca F; Oteo J; Pascual Á; Martínez-Martínez L; Domingo-Calap P; Bou G; Tomás M;
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0090021. PubMed ID: 34228538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitomycin C as an Anti-Persister Strategy against
    Pacios O; Herrera-Espejo S; Armán L; Ibarguren-Quiles C; Blasco L; Bleriot I; Fernández-García L; Ortiz-Cartagena C; Paniagua M; Barrio-Pujante A; Aracil B; Cisneros JM; Pachón-Ibáñez ME; Tomás M
    Antibiotics (Basel); 2024 Aug; 13(9):. PubMed ID: 39334989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and Genomic Comparison of
    Pacios O; Fernández-García L; Bleriot I; Blasco L; Ambroa A; López M; Ortiz-Cartagena C; Cuenca FF; Oteo-Iglesias J; Pascual Á; Martínez-Martínez L; Domingo-Calap P; Tomás M
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062209
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of
    Zhang W; Guo Y; Yang Y; Dong D; Zheng Y; Zhu D; Hu F
    Microb Drug Resist; 2020 Mar; 26(3):204-210. PubMed ID: 31553260
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z; Kayacan C; Oncul O
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophage vB_kpnS-Kpn15: Unveiling its potential triumph against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae - Unraveling efficacy through innovative animal alternate models.
    Sathe N; Suphioglu C; Athan E; Kapat A
    Microb Pathog; 2024 Oct; 195():106891. PubMed ID: 39214425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Klebsiella-specific phage on multidrug-resistant Klebsiella pneumoniae- an experimental study.
    Shree S; Suman E; Kotian H; Paul SH; M SS
    Indian J Med Microbiol; 2024; 47():100515. PubMed ID: 37981030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016.
    Galani I; Souli M; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Antoniadou A;
    Eur J Clin Microbiol Infect Dis; 2019 Jun; 38(6):1143-1150. PubMed ID: 30825054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and Characterization of vB_kpnM_17-11, a Novel Phage Efficient Against Carbapenem-Resistant
    Bai J; Zhang F; Liang S; Chen Q; Wang W; Wang Y; Martín-Rodríguez AJ; Sjöling Å; Hu R; Zhou Y
    Front Cell Infect Microbiol; 2022; 12():897531. PubMed ID: 35865823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Porins and bla
    Balabanian G; Rose M; Manning N; Landman D; Quale J
    Microb Drug Resist; 2018 Sep; 24(7):877-881. PubMed ID: 29782237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae.
    Poirel L; Kieffer N; Nordmann P
    J Antimicrob Chemother; 2016 Jan; 71(1):156-61. PubMed ID: 26416781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo.
    Göttig S; Frank D; Mungo E; Nolte A; Hogardt M; Besier S; Wichelhaus TA
    J Antimicrob Chemother; 2019 Nov; 74(11):3211-3216. PubMed ID: 31365094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Cha R
    Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of
    Tan D; Zhang Y; Cheng M; Le S; Gu J; Bao J; Qin J; Guo X; Zhu T
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31752386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48-positive Klebsiella pneumoniae strains.
    Evren E; Azap OK; Çolakoğlu Ş; Arslan H
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):335-8. PubMed ID: 23726147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacterales.
    Biagi M; Lee M; Wu T; Shajee A; Patel S; Deshpande LM; Mendes RE; Wenzler E
    Diagn Microbiol Infect Dis; 2022 Jun; 103(2):115674. PubMed ID: 35398608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation, Identification, and Biological Characterization of Phage vB_KpnM_KpVB3 Targeting Carbapenem-Resistant Klebsiella pneumoniae ST11.
    Liu S; Xu H; Cao R; Yang Z; Li X
    J Glob Antimicrob Resist; 2024 Jun; 37():179-184. PubMed ID: 38561142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of multidrug-resistant (MDR) Klebsiella pneumoniae harboring several β-lactamase and integron genes collected from several hospitals in the north of Iran.
    Farhadi M; Ahanjan M; Goli HR; Haghshenas MR; Gholami M
    Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):70. PubMed ID: 34583687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
    Shi WF; Zhou J; Qin JP
    Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of
    Aslam B; Siddique MH; Siddique AB; Shafique M; Muzammil S; Khurshid M; Rasool MH; Ahmad M; Chaudhry TH; Amir A; Salman M; Baloch Z; Alturki NA; Alzamami A
    Infect Drug Resist; 2022; 15():5795-5811. PubMed ID: 36213765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.